Webster Kate E, Feller Julian A, Hartnett Nigel, Leigh Warren B, Richmond Anneka K
School of Allied Health, La Trobe University, Melbourne, Australia
OrthoSport Victoria, Epworth HealthCare, Melbourne, Australia.
Am J Sports Med. 2016 Jan;44(1):83-90. doi: 10.1177/0363546515611886. Epub 2015 Nov 17.
Numerous studies have compared patellar tendon (PT) and hamstring tendon (HS) anterior cruciate ligament (ACL) reconstructions in the short to midterm, but fewer long-term results have been published.
There will be no difference in functional outcome between ACL reconstruction performed with PT and HS grafts, but PT grafts will have more donor site morbidity.
Randomized controlled trial; Level of evidence, 1.
Sixty-five patients undergoing ACL reconstruction were randomized to receive either a PT graft or a 4-strand HS graft. Early results were reported at 4, 8, 12, 24, and 36 months. Forty-seven patients (22 of 31 PT and 25 of 34 HS) were reviewed at a mean of 15.3 years.
Four graft ruptures (1 PT, 3 HS) and 6 contralateral ACL injuries (4 PT, 2 HS) occurred in the group that was reviewed. There was no statistically significant difference between the groups for any of the variables measured. There was a similar incidence of anterior knee pain and kneeling pain in both groups. The previously observed increased extension deficit in the PT group at 3 years was not present at 15 years, and there was no significant between-group difference in knee laxity. A higher proportion of patients in the PT group were participating in sport on a weekly basis (73% PT, 48% HS; P = .05). There was no difference in the degree of osteoarthritis between the groups.
This randomized controlled trial showed that HS and PT ACL reconstructions have comparable results at an average 15-year follow-up. Contrary to the study hypothesis, some of the graft differences seen at earlier review were not present at 15 years, and patients with PT grafts were more active in sport participation. Overall, both graft types provided good long-term subjective and objective outcomes.
众多研究已对髌腱(PT)和腘绳肌腱(HS)用于前交叉韧带(ACL)重建的短期至中期效果进行了比较,但长期结果的报道较少。
使用PT和HS移植物进行ACL重建后的功能结果无差异,但PT移植物的供区并发症更多。
随机对照试验;证据等级,1级。
65例行ACL重建的患者被随机分为接受PT移植物或4股HS移植物两组。在4、8、12、24和36个月时报告早期结果。对47例患者(31例PT组中的22例和34例HS组中的25例)进行了平均15.3年的随访。
在接受随访的组中发生了4例移植物断裂(1例PT,3例HS)和6例对侧ACL损伤(4例PT,2例HS)。两组间所测量的任何变量均无统计学显著差异。两组的前膝痛和跪痛发生率相似。先前观察到的PT组在3年时伸直受限增加的情况在15年时未出现,且两组间膝关节松弛度无显著差异。PT组中每周参加体育活动的患者比例更高(PT组为73%,HS组为48%;P = 0.05)。两组间骨关节炎程度无差异。
这项随机对照试验表明HS和PT ACL重建在平均15年的随访中结果相当。与研究假设相反,早期随访中所见的一些移植物差异在15年时未出现,且接受PT移植物的患者在体育活动参与方面更积极。总体而言,两种移植物类型均提供了良好的长期主观和客观结果。